| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ARCA biopharma, Inc. (NASDAQ: ABIO)
ABIO Technical Analysis
4
| As on 31st Oct 2017 ABIO Share Price closed @ 1.21 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.16 & Sell for SHORT-TERM with Stoploss of 1.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ABIO Share Price
| Open | 1.25 | Change | Price | % |
| High | 1.30 | 1 Day | 0.01 | 0.83 |
| Low | 1.20 | 1 Week | 0.00 | 0.00 |
| Close | 1.21 | 1 Month | -0.34 | -21.94 |
| Volume | 22986 | 1 Year | -1.14 | -48.51 |
| 52 Week High 3.00 | 52 Week Low 1.05 | ||||
NASDAQ USA Most Active Stocks
| YHOO | 52.58 | 0.00% |
| FNFG | 10.18 | -0.20% |
| DELL | 13.86 | 0.22% |
| RFMD | 16.59 | -2.07% |
| MU | 44.31 | 6.39% |
| RIMM | 13.03 | 0.39% |
| BBEP | 0.12 | 0.00% |
| GTAT | 0.44 | 0.00% |
| SUSQ | 14.20 | -0.77% |
| INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ABIO Daily Charts |
ABIO Intraday Charts |
Whats New @ Bazaartrend |
ABIO Free Analysis |
|
|
ABIO Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 1.30 |
| RESISTANCE | 1.26 |
| SUPPORT | 1.16 |
| SUPPORT | 1.12 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
ABIO Target for Month January
| 4th UP TARGET | 2.37 |
| 3rd UP TARGET | 2 |
| 2nd UP TARGET | 1.77 |
| 1st UP TARGET | 1.54 |
| 1st DOWN TARGET | 0.88 |
| 2nd DOWN TARGET | 0.65 |
| 3rd DOWN TARGET | 0.42 |
| 4th DOWN TARGET | 0.05 |
ABIO Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
ABIO Target for Year 2021
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
ARCA biopharma, Inc. ( NASDAQ USA Symbol : ABIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ABIO Business Profile
ARCA biopharma, Inc. (ARCA), incorporated in 1992, is a bio-pharmaceutical company. The Company’s principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA’s lead product candidate is Gencaro TM (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF).
ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases.The Company has collaborated with LabCorp to develop the Gencaro Test, a companion test for the genetic markers that may predict clinical response to Gencaro. ARCA’s product candidate is Gencaro (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF).
Gencaro (bucindolol hydrochloride) is a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of AF. Gencaro is considered part of the beta-blocker class of compounds because of its property of blocking both beta-1 and beta-2 receptors in the cardiac nervous system.
The Company Address is Suite 200, 8001 Arista Place, BROOMFIELD CO 80021.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
